Grifols, S.A. (GRF.MC)
| Previous close | 12.56 |
| Open | 12.52 |
| Bid | 12.52 x 0 |
| Ask | 12.55 x 0 |
| Day's range | 12.48 - 12.70 |
| 52-week range | 7.82 - 20.28 |
| Volume | |
| Avg. volume | 1,692,339 |
| Market cap | 7.337B |
| Beta (5Y monthly) | 0.33 |
| PE ratio (TTM) | 13.92 |
| EPS (TTM) | 0.90 |
| Earnings date | 28 Jul 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 03 Jun 2021 |
| 1y target est | 19.83 |
- Reuters
Spanish pharmaceuticals firm Grifols reports 30% drop in nine-month profit
Spanish pharmaceutical company Grifols reported a 30% drop in nine-month net profit on Tuesday, due in part to acquisition costs. Grifols said it was still on track to meet its full-year financial targets, but its shares fell 4.2% in morning trade. The company, which uses blood plasma to make medicines, saw its business severely hit by the pandemic as blood collection was halted in many countries.
- Reuters
Grifols says U.S. blood donors' lawsuit won't have material impact, shares down
Spanish pharma group Grifols said on Friday a lawsuit filed in the United States by blood donors who claim the company violated their privacy would have no material impact, after a report in newspaper El Economista sent the shares sharply lower. The company said about 54,000 donors in Illinois had filed a lawsuit claiming Grifols breached data protection regulations, confirming the newspaper report. Grifols shares were down 5.3% on Friday morning, briefly the worst performer on the blue-chip Ibex-35 index, which was down 2.1%.
- Reuters
Grifols appoints executive chairman as seeks to speed recovery
Grifols appointed an executive chairman on Monday, as the Spanish pharmaceutical company strives to recover from a pandemic-related hit and a 49% drop in its shares so far this year. Steven F. Mayer, an independent board member since 2011 and a former senior managing director of Cerberus Global Private Equity, will become executive chairman, effective immediately. The company's outgoing non-executive chairman, Victor Grifols Roura, who was chief executive from 1987 to 2016, has been named honorary chairman.
